Occupational airborne allergic contact dermatitis to invasive Compositae species treated with abrocitinib: A case report
- 29 August 2022
- journal article
- editorial
- Published by Wiley in Contact Dermatitis
- Vol. 87 (6) , 542-544
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Novel insights into contact dermatitisJournal of Allergy and Clinical Immunology, 2022
- Janus kinase inhibitors in dermatology: Part II. A comprehensive reviewJournal of the American Academy of Dermatology, 2022
- Characterization of Residual Facial Dermatitis during Dupilumab Therapy: A Retrospective Chart Review to Delineate the Potential Role of Expanded Series Patch TestingDermatitis®, 2021
- Allergic contact dermatitis to Compositae: A possible cause of dupilumab‐associated facial and neck dermatitis in atopic dermatitis patients?Contact Dermatitis, 2021
- Severe Airborne Allergic Contact Dermatitis From the Invasive Species Oncosiphon piluliferum (Globe Chamomile)Dermatitis®, 2021
- Development or Exacerbation of Head and Neck Dermatitis in Patients Treated for Atopic Dermatitis With DupilumabJAMA Dermatology, 2019
- Clinical patterns of Compositae dermatitis in Danish monosensitized patientsContact Dermatitis, 2017
- The JAK-STAT Pathway: Impact on Human Disease and Therapeutic InterventionAnnual Review of Medicine, 2015
- Effects of the Janus Kinase Inhibitor CP-690550 (Tofacitinib) in a Rat Model of Oxazolone-Induced Chronic DermatitisPharmacology, 2013
- Isolation and identification of antiplasmodial sesquiterpene lactones from Oncosiphon piluliferumJournal of Ethnopharmacology, 2007